← Search

Table · study · 2026

IL-33/IL1RL1 (ST2) signalling drives immune suppression in HPV-mediated epithelial hyperplasia

Listed in NCBI GEO

Interleukin 33 (IL-33), an alarmin cytokine binding to IL1RL1 (ST2) receptor, plays a pleiotropic and controversial role in cancer.

Description

Using a human papillomavirus (HPV) E7 oncoprotein-mediated murine model of cutaneous epithelial hyperplasia, we systematically characterised the interactions of epithelial cells and immune cells regulated by IL-33 and IL1RL1. Integration of single-cell RNA sequencing and flow cytometry data revealed that hyperplastic skin contains a unique basal epithelial cell phenotype expressing IL-33, and increased numbers of IL1RL1+Foxp3+ regulatory T cells (Tregs) compared to normal skin.

Using spatial transcriptomics, we demonstrate that IL1RL1+Foxp3+Tregs were in close proximity to IL-33-expressing cells. The translocation of IL-33 from the nucleus to the cytoplasm is associated with its bioactivity, and we show that IL-33 protein accumulates in the cytoplasm in epithelial cells of hyperplastic skin, compared to nucleic location in normal epithelium. These results imply that the nuclear release of IL-33 may lead to the recruitment and activation of IL1RL1+Foxp3+Tregs to mediate immune suppression.

Read the rest (2 more)

To test the biological relevance of IL1RL1-signalling in hyperplastic skin, we used a skin graft model where the HPV E7 oncoprotein-mediated hyperplastic skin is tolerated when grafted to an immunocompetent recipient mouse. Ablation of the IL1RL1 gene from HPV-mediated hyperplastic skin and the graft host led to partial rejection of skin grafts, demonstrating that IL1RL1 plays a vital role in mediating immune suppression in this model.

The IL1RL1 signalling pathway, therefore, represents a potential therapeutic target for epithelial cancer treatment.

Links

Topics

Stated by source
Mus musculus · Other
From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75% · Single-cell RNA sequencing 75%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE29794714 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:othersource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:single-cell-rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title